Reversal of neuromuscular blockade in humans by neostigmine and edrophonium: A mathematical model
- 26 Downloads
- 5 Citations
Abstract
Generalizations of the integrated model describing the interaction of nondepolarizing neuromuscular blocking drugs with reversible anticholinesterase drugs described in Unadkat et al.(1) are reported. The models can deal with possible incomplete reversal (irreversible block) and/or noninstantaneous anticholinesterase kinetics. Experimental data were obtained from 22 human volunteers. Different levels of steady-state vecuronium block were induced in each volunteer (in the range of 50% to 95%), and reversed by short infusions of edrophonium (10 volunteers) or neostigmine (12 volunteers). Edrophonium or neostigmine concentrations and twitch tension (measured as the force of thumb adduction) were measured. The generalized integrated models fit the data well. In the case of neostigmine we find a nondistributional delay in its action. We relate this delay to the slow decarbamylation rate of the (neostigmine-induced) carbamylated anticholinesterase observed in vitro,and are able to model such noninstantaneous anticholinesterase kinetic processes. For both edrophonium and neostigmine we detect an inverse relationship between the induced) level of initial block and maximal percentage recovery.
Key words
neuromuscular blockade neostigmine edrophonium vecuronium anticholinesterase drugsPreview
Unable to display preview. Download preview PDF.
References
- 1.J. D. Unadkat, L. B. Sheiner, P. J. Hennis, R. Cronnelly, R. D. Miller, and M. Sharma. An integrated model for the interaction of muscle relaxants with their antagonists.J. Appl. Physiol. 61:1593–1598 (1986).PubMedGoogle Scholar
- 2.R. Cronnelly, R. B. Morris, and R. D. Miller. Edrophonium: Duration of action and atropine requirements in human during halothane anesthesia.Anesthesiology 57:261 (1982).PubMedCrossRefGoogle Scholar
- 3.R. D. Miller and V. J. Savarese. Pharmacology of muscle relaxants and their antagonists. In R. D. Miller (ed.),Anesthesia, 3rd ed., Churchill-Livingstone, New York, 1990, pp. 418–423.Google Scholar
- 4.R. P. Fodgull and R. D. Miller. Antagonism of d-tubocurarine and pancuronium-induced neuromuscular blockades by pyridostigmine in men.Anesthesiology 39:504 (1973).CrossRefGoogle Scholar
- 5.R. D. Miller, C. P. Jarson, Jr., and W. L. Way. Comparative antagonism of d-tubocura-rine-, gullamine-, and paucuronium-induced neuromuscular blockade by neostigmine.Anesthesiology 36:503 (1972).CrossRefGoogle Scholar
- 6.G. Sergé. Kinetics of interaction between drugs and biological systems.Farmaco 23:907–918 (1968).Google Scholar
- 7.R. M. Dawson and M. Poretski. Phenyldichlorophosphate as an aid in studies of decarbamylation of carbamylated acetylcholinesterase.Anal. Biochem. 170:451–455 (1988).PubMedCrossRefGoogle Scholar
- 8.I. B. Wilson. The interaction of tensilon and neostigmine with acetylcholinesterase.Arch. Int. Pharmacol. Ther. 109:204–213 (1955).Google Scholar
- 9.S. L. Beal, and L. B. Sheiner.NONMEM Users Guide Part 1: Users Basic Guide, 2nd ed.Division of Clinical Pharmacology, University of California at San Francisco, 1980.Google Scholar
- 10.M. G. M. DeRuyter, R. Cronnelly, and N. Castagnoli. Reversed-phase, ion-pair liquid chromatography of quaternary ammonium compounds: determination of pyridostigmine, neostigmine, and edrophonium in biological fluids.J. Chromatog. 183:193–201 (1980).CrossRefGoogle Scholar
- 11.T. Furuta, P. C. Canfell, F. P. Castagnoli, M. L. Sharma, and R. D. Miller. Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection.J. Chromatog. 427:41–53 (1988).CrossRefGoogle Scholar